Skip to content

Assessment of Efficacy & Safety of Topical & Intracameral application of combination of tropicamide, phenylephrine and lidocaine in phacoemulsification surgery a new approach..

Assessment of Safety & Efficacy of Topical & Intracameral application of combination of tropicamide, phenylephrine and lidocaine in phacoemulsification surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035711
Enrollment
50
Registered
2021-08-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H250- Age-related incipient cataract Health Condition 2: H259- Unspecified age-related cataract Health Condition 3: H259- Unspecified age-related cataract

Interventions

Intervention1: Topical & Intracameral application of combination of tropicamide, phenylephrine and lidocaine: 2 drops Topical & 0.2cc Intracameral application of combination of tropicamide, phenylephr

Sponsors

Dr Dhruvil Nayak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients who have demonstrated, at a previous visit, a satisfactory pupil dilation ( >6mm) with topical mydriatic therapy. All patients aged 40 to 70 years with senile cataract undergoing uncomplicated phacoemulsification surgery and willing to give written and informed consent for the study. Uncomplicated Cataract Cooperative patients

Exclusion criteria

Exclusion criteria: Patients having Corneal pathology Pupillary disorders Retinal pathology Increased intraocular pressure p/h/o Psychiatric illness uncontrolled Hypertension h/o hypersensitivity to amide group of drugs h/o ocular surgery Pregnant patients All the surgeries will be carried out under Stand by Anesthetic patients turning uncooperative will be given sedation and excluded from the study

Design outcomes

Primary

MeasureTime frame
To Study anaesthetic & mydriatic effect of the combination.Timepoint: During time period of cataract Surgery

Secondary

MeasureTime frame
To study the post operative iridocyclitis. To study Post operative macular oedema by OCT Macula To Study the post operative corneal changes by Anterior Segment OCT and Slit lamp examinationTimepoint: within 3 days post surgery

Countries

India

Contacts

Public ContactDr Dhruvil Nayak

Dept of Ophthalmology Govt Medical College and Sir T Hospital,Bhavnagar

trivedi_harish@yahoo.co.in9428009959

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026